Diabetes News and Research

Latest Diabetes News and Research

Study estimates the global prevalence of dementia in 2050

The number of adults (aged 40 years and older) living with dementia worldwide is expected to nearly triple, from an estimated 57 million in 2019 to 153 million in 2050, due primarily to population growth and population aging.

6 Jan 2022

Maternal thyroid hormone levels during pregnancy may predict children's behavioral problems

Thyroid hormone levels during pregnancy may predict preschool boys' emotional and behavioral problems, according to a study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

6 Jan 2022

Study reinforces the link between microglia and some cases of brain disease

Certain subtle differences in DNA sequences are known to raise the chances a person may develop Alzheimer's or Parkinson's disease.

6 Jan 2022

Researchers identify how a critical schistosomiasis drug works on the molecular level

Independent teams from Texas Biomedical Research Institute and the Medical College of Wisconsin have published two papers in Science Translational Medicine identifying how the only approved drug to treat schistosomiasis, a widespread parasitic worm infection, works on the molecular level.

6 Jan 2022

New study strengthens the link between sleep-disordered breathing and gestational diabetes

Sleep-disordered breathing in early pregnancy is associated with insulin resistance or difficulty clearing glucose from the blood, suggests a small study funded by the National Institutes of Health.

6 Jan 2022

Salk professor receives $1.2 million from Larry L. Hillblom Foundation for diabetes research

Professor Ronald Evans will receive $1.2 million over four years as part of a Network Grant from the Larry L. Hillblom Foundation to examine a molecular pathway that regulates blood sugar and fat independent of insulin.

6 Jan 2022

More is better than less when it comes to physical activity and cardiovascular disease

In this interview, we speak to Esmée Bakker about her latest research which investigated the impact physical activity has on cardiovascular disease.

6 Jan 2022

How diet, supplements and lifestyle changes can help battle COVID

A recent editorial in the journal Nutrients emphasizes how efficacious non-pharmacological interventions in conjunction with the promotion of healthy lifestyle and dietary patterns may improve overall health status and reduce the risk of infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as well as the potential adverse effects of coronavirus disease 2019 (COVID-19).

6 Jan 2022

LIVE-AIR trial demonstrates efficacy of Lenzilumab for treatment of COVID patients with decreased oxygen saturation

The LIVE-AIR phase 3 clinical trial is associated with early treatment of hyperinflammatory response with the humanized monoclonal antibody lenzilumab in COVID-19 patients with decreased oxygen saturation. The study results are posted to the medRxiv* preprint server.

6 Jan 2022

A new model for predicting COVID-19 severity at diagnosis

Researchers estimate the probabilities of hospitalization and mortality from COVID-19 according to individual risk factors and number of vaccine doses.

5 Jan 2022

FAU researchers urge to prescribe aspirin based on benefit-to-risk not age

Recent guidelines have restricted aspirin use in the primary prevention of cardiovascular disease to patients under 70, and more recent guidance to patients under 60. Yet, the risks of heart attacks and strokes increase markedly with age.

5 Jan 2022

Drugs that block mineralocorticoid receptor may help protect bone cells during aging

Drugs we take like prednisone can weaken our bones and so can aging, and scientists working to prevent both have some of the first evidence that the best target may not be the logical one.

5 Jan 2022

Basic health beliefs and demographics associated with risk factors for cardiovascular disease

Minnesota has the lowest age-adjusted heart disease mortality in the U.S.; yet, African American adults 35 to 63 have nearly double the rate of death from cardiovascular disease, compared to their white counterparts.

5 Jan 2022

Empire Discovery Institute collaborates with Novo Nordisk to launch new drug discovery initiative

Empire Discovery Institute entered into a five-year collaborative research partnership with global pharmaceutical company Novo Nordisk A/S to launch LeapRx, a new initiative where EDI and Novo Nordisk will co-invest, incubate and accelerate innovative drug discovery and development projects from its academic partners.

4 Jan 2022

Diabetes News and Research

Latest Diabetes News and Research

Study estimates the global prevalence of dementia in 2050

Maternal thyroid hormone levels during pregnancy may predict children's behavioral problems

Study reinforces the link between microglia and some cases of brain disease

Researchers identify how a critical schistosomiasis drug works on the molecular level

New study strengthens the link between sleep-disordered breathing and gestational diabetes

Salk professor receives $1.2 million from Larry L. Hillblom Foundation for diabetes research

More is better than less when it comes to physical activity and cardiovascular disease

How diet, supplements and lifestyle changes can help battle COVID

LIVE-AIR trial demonstrates efficacy of Lenzilumab for treatment of COVID patients with decreased oxygen saturation

A new model for predicting COVID-19 severity at diagnosis

FAU researchers urge to prescribe aspirin based on benefit-to-risk not age

Drugs that block mineralocorticoid receptor may help protect bone cells during aging

Basic health beliefs and demographics associated with risk factors for cardiovascular disease

Empire Discovery Institute collaborates with Novo Nordisk to launch new drug discovery initiative

Both symptomatic and asymptomatic COVID-19 associated with increased risk of cardiovascular events

New Potocsnak Longevity Institute aims to extend human 'healthspan'

New insights into how tiny bacteria from the environment have adapted to live inside humans

New Better Health marketing campaign highlights six benefits of losing excess weight

Scientists analyze the causes of deaths and disabilities in Colorado over a 29-year period

Study finds increased oxidative stress, oxidant damage and glutathione deficiency in COVID-19 patients

Innovation in neuroscience drug discovery - eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Diabetes News and Research

Latest Diabetes News and Research

Innovation in neuroscience drug discovery - eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in